Proteomics

Dataset Information

0

Anti-Cancer potential of a new Derivative of Caffeic Acid Phenethyl Ester targeting the centrosome


ABSTRACT: Anaplastic Large Cell Lymphoma (ALCL) is an aggressive T-cell lymphoma affecting children and young adults. About 30% of patients develop therapy resistance therefore new precision medicine drugs are highly warranted. Multiple rounds of structure-activity optimization of Caffeic Acid Phenethyl Ester have resulted in CM14. CM14 causes upregulation of genes involved in oxidative stress response and downregulation of DNA replication genes leading to G2/M arrest and subsequent apoptosis induction. In accordance with this, an unbiased proteomics approach, confocal microscopy and molecular modeling showed that TUBGCP2, member of the centrosomal γ-TuRC complex, is a direct interaction partner of CM14. CM14 overcomes ALK inhibitor resistance in ALCL and is also active in T-cell Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia. Interestingly, CM14 also induced cell death in docetaxel-resistant prostate cancer cells thus suggesting an unexpected role in solid cancers. Thus, we synthesized and thoroughly characterized a novel TUBGCP2 targeting drug that is active in ALCL but has also potential for other malignancies.

INSTRUMENT(S): timsTOF Pro

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Cell Culture

SUBMITTER: Katerina Hanakova  

LAB HEAD: Zbynek Zdrahal

PROVIDER: PXD061079 | Pride | 2025-03-06

REPOSITORIES: Pride

Dataset's files

Source:

Similar Datasets

2016-04-20 | PXD003425 | Pride
2024-10-17 | PXD052563 | Pride
2024-08-23 | PXD041580 | Pride
2024-01-04 | PXD045327 | Pride
2023-09-11 | PXD042668 | Pride
2025-03-19 | PXD052662 | Pride
2021-11-03 | PXD018712 | Pride
2012-08-30 | E-GEOD-36200 | biostudies-arrayexpress
2015-05-16 | E-GEOD-68950 | biostudies-arrayexpress
2020-12-18 | PXD014691 | Pride